GTR Home > Tests > Search results - MRE11A[gene]

Apply filters

Showing tests for all 1845 conditions

Compare labs

Your search term can be found in tests with a total of 1845 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for 4361[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 29 tests for 1845 conditions in 12 labs

CMicrocephaly MRE11A related

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CMicrocephaly MRE11A related

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAtaxia telangiectasia like disorder

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CBreast ovarian cancer panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (14)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CAtaxia-telangiectasia-like disorder via the MRE11A Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHereditary Breast and Ovarian Cancer Syndrome - HBOC EXPANDED NextGen Sequencing (NGS) Panel and Deletion/Duplication Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (11)
Total targets (20)

CChromosomal Instability Syndromes NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (8)

CAtaxia and differential diagnoses Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (174)
Total targets (147)

CBreast and Ovarian Cancer Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (7)
Total targets (35)

CMRE11A-related cancer risk

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAtaxia telangiectasia like disorder (sequence analysis of MRE11A gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHereditary breast cancer, moderate-risk panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (10)

CHereditary breast cancer, extended panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (17)

CPrimary Antibody Deficiency Panel, Sequencing (35 Genes) and Deletion/Duplication (26 Genes)

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (37)
Total targets (35)

CHyper IgM Syndrome Panel, Sequencing (12 Genes) and Deletion/Duplication (10 Genes)

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (13)
Total targets (12)

CMicrocephaly and Dwarfism

Lab: Institute of Human Genetics Cologne University Cologne, Nordrhein-Westfalen, Germany
Conditions
Test targets
Methods
  • S Mutation scanning of the entire coding region

CMRE11A

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CChromosomal Instability Syndromes NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (7)

CHereditary breast and gynecologic cancers (Women's hereditary cancers)

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (28)
Total targets (22)

Showing 1 to 20 of 29 tests for 1845 conditions in 12 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.